JP Patent

JP2012532194A — 持続放出オンダンセトロン組成物を用いたｐｄｎｖ及びｐｏｎｖの処置方法

Assigned to Adare Pharma Solutions Inc · Expires 2012-12-13 · 13y expired

What this patent protects

本発明の持続放出オンダンセトロン組成物は、術後悪心・嘔吐（ＰＯＮＶ）及び／又は退院後悪心・嘔吐（ＰＤＮＶ）の処置に有用である。

USPTO Abstract

本発明の持続放出オンダンセトロン組成物は、術後悪心・嘔吐（ＰＯＮＶ）及び／又は退院後悪心・嘔吐（ＰＤＮＶ）の処置に有用である。

Drugs covered by this patent

Patent Metadata

Patent number
JP2012532194A
Jurisdiction
JP
Classification
—
Expires
2012-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Adare Pharma Solutions Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.